ArticleFrontiers in oncology2025
Headache as the initial symptom in two cases of multiple myeloma: a case report and literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple myeloma (MM) is a hematologic malignancy characterized by clonal proliferation of plasma cells. It typically manifests with bone pain, renal failure, anemia, and hypercalcemia. However, initial presentations can be atypical, potentially leading to diagnostic delays. We present two cases of MM in which the primary presenting symptom was severe and persistent headache. In both cases, headache was the presenting symptom that ultimately led to the diagnosis. The first case was attributed to hyperviscosity syndrome, while the second resulted from an intracranial plasmacytoma with dural involvement. These cases highlight the importance of including hematological malignancies in the differential diagnosis of new, severe, or atypical headaches, particularly when accompanied by nonspecific systemic symptoms such as fatigue or weight loss. Serum protein electrophoresis (SPEP) and the free light chain (FLC) ratio are critical initial investigations for suspected cases. Early recognition of such atypical presentation can significantly reduce diagnostic delay and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.